Optimisation of In Vitro Models of the Blood-Brain Barrier towards Recapitulation of In Vivo Responses

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmacokinetics and Pharmacodynamics".

Deadline for manuscript submissions: closed (20 May 2021) | Viewed by 168

Special Issue Editor


E-Mail Website
Guest Editor
1. School of Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland
2. National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland
Interests: vascular biology; blood brain barrier; nanomaterials; nanoparticles; endocrinology; inflammation; macrovasculature; microvasculature; endothelium; tight junctions; shear stress; hemodynamics

Special Issue Information

Dear Colleagues,

The blood–brain barrier is a complex, yet dynamic interface which is pivotal in maintaining homeostasis of the brain in humans. This highly organised and regulated structure is fundamental for survival; yet, this barrier, which evolved to protect humans, ironically prevents the successful delivery of neurotherapeutics to the brain. With the incidence of neurological disorders increasingly rapidly, the pharmaceutical industry has been tasked with developing innovative strategies which not only overcome the obstacle this barrier presents, but also are effective therapeutics, equally safe and high in quality. As such, appropriate models which accurately reflect the sophisticated physiology of this human neurovascular unit towards improvements to the drug delivery pipeline in this area are continuously sought.

Recent advancements in three-dimensional modelling, microfluidics, and cell culture have overcome many of the limitations of these approaches, and efforts towards the development of new neurotherapeutics have seen an improvement in drugs’ efficacy, quality, and safety as a result. This Special Issue is intended to highlight the recent advancements in approaches to blood–brain barrier modelling and how such approaches have been used to test and validate the translational potential of drug candidates for neurological diseases which pose a significant risk to the global population. Topics of interest of this Special Issue include, but are not limited to, the following: lab-on-a-chip, spheroids, three-dimensional cell culture, microfluidics, selective targeting, nanotherapeutics, translational evidence.

Dr. Keith Rochfort
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lab-on-a-chip
  • spheroids
  • three-dimensional cell culture
  • pluripotent stem cells
  • microfluidics
  • hemodynamics
  • cell junctions
  • active Transporters
  • selective targeting
  • nanotherapeutics
  • translational evidences

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop